Copper-Free Click Chemistry and Bioorthogonal Reactions: The New Engine for Next-Generation ADCs
Antibody-Drug Conjugates (ADCs) have unequivocally transformed the landscape of targeted oncology. By marrying the precision of monoclonal antibodies with the lethal potency of cytotoxic payloads, ADCs offer a "magic bullet" approach to cancer therapy. However, despite their clinical success, traditional bioconjugation methods—such as stochastic modification of lysine or cysteine...
0 Kommentare 0 Anteile 7 Ansichten 0 Vorschau